Affinity (Drug Discovery) Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 26

Employees

  • Latest Deal Type
  • Series A1

  • Investors
  • 6

Affinity (Drug Discovery) General Information

Description

Developer of tumor microenvironment-responsive pharmaceuticals designed for the reduction of systemic toxicity in cancer treatments. The company utilizes a proprietary tumor microenvironment-activated technology platform to develop pharmaceuticals that selectively deliver drugs to tumor sites, enabling healthcare providers to access oncology treatments with reduced systemic side effects and improved therapeutic efficacy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3rd Floor, Building 1
  • Number 368 Zhangjiang Road, Pudong New Area
  • Shanghai, 201203
  • China
+86 130
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 3rd Floor, Building 1
  • Number 368 Zhangjiang Road, Pudong New Area
  • Shanghai, 201203
  • China
+86 130

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Affinity (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A1) 06-Jul-2022 Completed Generating Revenue
2. Later Stage VC (Series A) 01-Sep-2021 Completed Generating Revenue
1. Later Stage VC 16-Jul-2019 $8.72M $8.72M Completed Generating Revenue
To view Affinity (Drug Discovery)’s complete valuation and funding history, request access »

Affinity (Drug Discovery) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Affinity (Drug Discovery) Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ciit Asset Management Asset Manager Minority
Hongfu Asset Management Asset Manager Minority
Hygeia Capital Venture Capital Minority
SDIC Venture Capital Venture Capital Minority
Panlin Capital Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Affinity (Drug Discovery) FAQs

  • When was Affinity (Drug Discovery) founded?

    Affinity (Drug Discovery) was founded in 2011.

  • Where is Affinity (Drug Discovery) headquartered?

    Affinity (Drug Discovery) is headquartered in Shanghai, China.

  • What is the size of Affinity (Drug Discovery)?

    Affinity (Drug Discovery) has 26 total employees.

  • What industry is Affinity (Drug Discovery) in?

    Affinity (Drug Discovery)’s primary industry is Drug Discovery.

  • Is Affinity (Drug Discovery) a private or public company?

    Affinity (Drug Discovery) is a Private company.

  • What is Affinity (Drug Discovery)’s current revenue?

    The current revenue for Affinity (Drug Discovery) is .

  • How much funding has Affinity (Drug Discovery) raised over time?

    Affinity (Drug Discovery) has raised $8.72M.

  • Who are Affinity (Drug Discovery)’s investors?

    Ciit Asset Management, Hongfu Asset Management, Hygeia Capital, SDIC Venture Capital, and Panlin Capital are 5 of 6 investors who have invested in Affinity (Drug Discovery).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process